Types of Work

["2018"]

[[["Meeting Abstracts",539],["Journal Articles",364],["Book Sections",25],["Reviews",13],["Research Letters",3],["Conference Papers",2],["Editorials",2],["Miscellaneous",2],["Books Whole",1],["Correspondences",1]]]

[952]

Popular keywords

• adult
• aged
• article
• controlled study
• female
• human
• major clinical study
• male
• middle aged
• priority journal

Recent Works

1. A phase II trial of reduced dose brentuximab vedotin for cutaneous T‐cell lymphomas

   Meeting Abstract

   Khan, N.; Noor, S.; Geller, S.; Khodadoust, M. S.; Kheterpal, M.; Hancock, H.; Davey, T.; Ryu, S.; Perez, L.; Lares, A.; more...
   Hematological Oncology (2021)

   Fulltext@MSK | Save
2. The combination of duvelisib and romidepsin (DR) is highly active against relapsed/refractory peripheral T‐cell lymphoma with low rates of transaminitis: Final results

   Meeting Abstract

   Horwitz, S. M.; Moskowitz, A. J.; Mehta‐Shah, N.; Jacobsen, E. D.; Khodadoust, M. S.; Ganesan, N.; Drill, E.; Hancock, H.; Davey, T.; Myskowski, P.; more...
   Hematological Oncology (2021)

   Fulltext@MSK | Save
3. Safety and effectiveness of weekly carfilzomib, lenalidomide, dexamethasone, and daratumumab combination therapy for patients with newly diagnosed multiple myeloma the MANHATTAN nonrandomized clinical trial

   Journal Article

   Landgren, O.; Hultcrantz, M.; Diamond, B.; Lesokhin, A. M.; Mailankody, S.; Hassoun, H.; Tan, C.; Shah, U. A.; Lu, S. X.; Salcedo, M.; more...
   JAMA Oncology (2021)

   Fulltext@MSK | Save